Price Alert

Syros Pharmaceuticals Inc... (SYRS)

NASDAQ: SYRS · Real-Time Price · USD

0.03

0.00 (19.52%)

At close: Jun 09, 2025, 3:26 PM

Syros Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	58.27M	78.96M	83.52M	139.53M	112.22M	115.44M	104.77M	167.47M	171.53M	59.06M	69.58M	92.3M	115.42M	160.91M	222.14M
Short-Term Investments	n/a	n/a	24.78M	n/a	n/a	28.54M	61.04M	34.84M	72.95M	27.22M	40.69M	38.07M	30.16M	21.11M	n/a
Long-Term Investments	n/a	2.12M	2.12M	2.12M	3.09M	3.09M	3.09M	3.09M	3.09M	3.09M	2.64M	13.04M	21.12M	13.26M	3.09M
Other Long-Term Assets	3.48M	1.46M	1.55M	1.59M	2.11M	2.23M	4.65M	5.35M	3.67M	5.32M	6.24M	6.03M	5.5M	5.53M	1.74M
Receivables	n/a	n/a	n/a	n/a	1.67M	1.76M	1.76M	1.69M	1.77M	2.29M	3.18M	2.98M	3.63M	2.18M	2.62M
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	5.66M	5.96M	3.9M	5.45M	8.63M	6.89M	6.08M	7.39M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	63.93M	84.92M	112.2M	144.98M	122.52M	152.63M	173.64M	211.39M	252.31M	91.94M	116.48M	136.59M	153.27M	186.21M	226.68M
Property-Plant & Equipment	17.58M	18.22M	18.86M	19.48M	20.08M	23.04M	23.95M	24.66M	25.67M	25.89M	26.73M	27.29M	28.16M	28.73M	29.12M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	21.06M	21.8M	22.53M	23.19M	25.28M	28.35M	31.68M	33.09M	32.42M	34.29M	35.6M	46.35M	54.77M	47.53M	33.95M
Total Assets	85M	106.72M	134.73M	168.17M	147.79M	180.98M	205.32M	244.49M	284.73M	126.23M	152.08M	182.94M	208.04M	233.73M	260.63M
Account Payables	9.65M	7.47M	11.35M	11.54M	2.85M	6.69M	2.79M	6.41M	13.02M	6.12M	2.84M	3.69M	4.11M	3.67M	3.66M
Deferred Revenue	n/a	n/a	n/a	n/a	139K	2.19M	3.25M	4.33M	1.63M	3.59M	7.77M	10.18M	11.99M	12.12M	12.79M
Short-Term Debt	2.58M	2.5M	11.67M	8.99M	3.91M	2.17M	3.76M	n/a	2.07M	8.73M	3.73M	n/a	1.94M	1.87M	1.8M
Other Current Liabilities	8.79M	8.25M	n/a	6.83M	11.3M	10.12M	8.66M	9.44M	12.9M	12.93M	8.01M	9.28M	6M	5.11M	5.15M
Total Current Liabilities	28.39M	24.52M	37.3M	36.68M	28.39M	28.38M	23.55M	30.78M	38.42M	38.93M	27.59M	31.51M	29.88M	27.62M	27.37M
Long-Term Debt	41.08M	40.93M	29.71M	34.56M	39.41M	40.93M	39.12M	40.65M	40.51M	33.97M	38.77M	40.26M	40.07M	39.89M	39.72M
Other Long-Term Liabilities	10.08M	30.39M	34.77M	61.75M	24.55M	18.71M	15.61M	24.47M	55.23M	425K	581K	3.03M	5.59M	7.43M	12.04M
Total Long-Term Liabilities	67.73M	88.55M	82.37M	114.83M	83.1M	79.37M	75.02M	85.97M	117.13M	56.29M	61.75M	66.21M	72.1M	76.13M	83.38M
Total Liabilities	96.12M	113.07M	119.67M	151.51M	111.49M	107.74M	98.57M	116.75M	155.55M	95.22M	89.34M	97.72M	101.98M	103.76M	110.75M
Total Debt	60.23M	60.66M	61.67M	62.08M	62.46M	62.83M	63.17M	63.57M	63.97M	64.6M	64.89M	65.19M	65.47M	65.72M	65.97M
Book Value	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Book Value Per Share	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Common Stock	27K	26K	26K	26K	21K	20K	20K	20K	20K	62K	61K	61K	61K	61K	61K
Retained Earnings	-756.24M	-749.84M	-726.51M	-722.81M	-658.42M	-618.28M	-582.02M	-558.23M	-553.46M	-523.21M	-488.73M	-463.58M	-439.77M	-413.74M	-391.25M
Comprehensive Income	n/a	-0.00	-0.00	n/a	n/a	49K	263K	102K	-226K	-313K	-273K	-79K	-5K	-19K	n/a
Shareholders Equity	-11.12M	-6.35M	15.06M	16.66M	36.3M	73.24M	106.75M	127.74M	129.17M	31.02M	62.74M	85.22M	106.06M	129.98M	149.88M
Total Investments	2.12M	2.12M	26.9M	2.12M	3.09M	28.54M	61.04M	34.84M	72.95M	27.22M	43.32M	51.1M	51.28M	34.38M	3.09M